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THE ALKYLATING AGENT chlorambucil
has been reported to physically adsorb
without loss of alkylating activity to
certain serum proteins (Hopwood and
Stock, 1972; Linford, 1963a). Conse-
quently, attempts have been made to
adsorb chlorambucil to tumour specific
antibodies, in the hope that such con-
jugates would have the specificity of the
antibodies as well as the toxicity of the
drug. Both binding (Blakeslee and Ken-
nedy, 1974; Linford, 1963b; Ross, 1974)
and cytotoxicity studies (Davies and
O'Neill, 1973; Flechner, 1973; Ghose and
Nigam, 1972; Ghose et al., 1972; Rubens
and Dulbecco, 1974) of such conjugates
have been reported. However, the data
reported below indicate that an artefact
was probably responsible for previous
conclusions that active chlorambucil can
bind non-covalently to immunoglobulin
G; thus it will be necessary to re-evaluate
the various studies in which the cyto-
toxicity of free chlorambucil in the pres-
ence of cell specific antibodies was com-
pared with that of what now appears to
be a non-existent conjugate of chloram-
bucilwith antibody.
Ghose and Nigam (1972) and Davies
and O'Neill (1973) reported that signi-
ficant quantities of chemically active
chlorambucil, measured by a colorimetric
assay for alkylating compounds (Epstein,
Rosenthal and Ess, 1955), remained with
the y-globulin which had been incubated
under various conditions. In a more
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extensive series of experiments, Blakeslee
and Kennedy (1974) showed that, under a
wide variety of incubation conditions,
large amounts ofchlorambucil eluted from
a G-25 column together with the IgG
with which it had been incubated. Since
much of this drug could be separated
from the IgG by alcohol treatment, it was
not bound covalently to the protein.
Furthermore, they found that much ofthe
extractable drug retained its alkylating
activity.
Ross (1974) also used a G-25 column
to fractionate mixtures of chlorambucil
and IgG, and found chlorambucil eluting
together with the protein. However, he
suggested that this chlorambucil was
bound covalently to the IgG although its
residual alkylating activity was not evalu-
ated. Using a quite different approach
to the question, Hopwood andStock (1972)
showed that the presence of y-globulin
(bovine) did not affect the hydrolysis rate
of chlorambucil and concluded that the
drug did not physically bind to this
protein, though it did appear to bind to
albumin and to certain non-ionic deter-
gent molecules. This conclusion is con-
sistent with our most recent studies of the
interaction between chlorambucil and
rabbit IgG.
All of the studies which claimed to
demonstrate binding of chlorambucil to
y-globulin were based on the assumption
that any drug which did not bind chemi-
cally or physically to the protein duringD. BLAKESLEE, M. CHEN AND J. C. KENNEDY
E
cm It)
(N
w
IflJ
m
cc 0
Cl)
m
5 10 15 20 25 30
FRACTION NUMBER
Fie. Elution of the sodlium salt ofchlorambucil from a Sepha(lex G-25 (fine) column (a) immediately
after dissolution, (b) after 20 min incubationat 37°C, pH 9- 5, (c) after 60 min and (d) after 150 min.
The incubation was performed in a water-jacketed reaction vessel wN-ith the pH maintained by the
delivery of0.1 N NaOH by a pH-stat.
incubation of a mixture containing the
drug and the protein could be separated
quantitatively from the protein either by
dialysis or by gel filtration. This assump-
tion is incorrect.
Under a wide range of conditions, a
solution of the sodium salt of chloram-
bucil forms a significant amount of a
high molecular weight aggregate. This
is illustrated in the Fig. which shows the
G-25 elution profiles of chlorambucil after
various periods of incubation at 37°C and
pH 9-5. The aggregate (peak A) increases
with the duration of incubation. Peaks
B, C and D probably represent the forma-
tion of fully hydrolysed chlorambucil (B)
from dichloro chlorambucil (D) by way
of half-hydrolysed chlorambucil (C), as
was suggested by Ross (1974). The
nature of the chlorambucil in peak E is
unknown. If the column pH is lower
than eight, some or all of the aggregate
formed during the incubation is trapped
at the top of the gel bed and does not
emerge. It can subsequently be eluted
at higher pH.
The chlorambucil aggregate has a
molecular weight of 2 x 105 or more, as
evidenced by its total exclusion from all
grades of Sephadex up to and including
G-200. Consequently, the aggregate does
not appear to be polydisperse but seems
to occur only in a high molecular weight
form. It is completely non-dialysable.
However, it possesses the same alkylating
activity as does an equivalent amount of
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chlorambucil monomer, as measured by
its reaction with 4-(p-nitrobenzyl) pyri-
dine (Epstein et al., 1955) in ethanolic, but
not aqueous, solution. Thus, the aggre-
gate does not appear to be a covalent
polymer involving reaction of one or both
chloro groups with another portion of the
molecule. The isolated chlorambucil ag-
gregate hydrolyses very slowly in aqueous
solution; at least 80% of the original
alkylating activity remains after 3 h at
37°C. Very little activity is lost after
24 h at 4°C.
Aggregate formation occurs under all
conditions such that chlorambucil can
react with water or other anionic species
(pH > 6), but is minimal when these
reactions are very rapid, as for example
in the presence of abundant hydroxide
(pH > 12), carbonate (but not bicarbon-
ate) or thiosulphate anions. Fully hydro-
lysed chlorambucil, which is far more
soluble than dichloro chlorambucil, does
not form the aggregate. Aggregate form-
ation is greatest and most rapid at 37°C,
at low ionic strength and slightly alkaline
pH, and is decreased with increasing
concentration of NaCl. It forms slowly
in the cold and even brief warming by
holding a tube in the hand for a few
seconds greatly accelerates its formation.
These observations are consistent with
the formation of a stable chlorambucil
micelle with ionized carboxyl groups out-
wardly exposed surrounding non-polar
chloroethyl groups inside. However, the
possibility that the chlorambucil we used
(donated by Burroughs Welcome & Co.
(Canada) Ltd) was aggregating with an
impurity cannot be excluded.
As might be predicted from its high
stability and low reactivity (in aqueous
solution), the aggregate possesses little
cytotoxicity against cultured mouse tum-
our cells when compared with an equal
amount of monomeric chlorambucil, and
the combination of tumour reactive anti-
body and chlorambucil aggregate is not
significantly more cytotoxic than is the
antibody alone. On the other hand, the
aggregate is slowly toxic to cultured
mouse peritoneal macrophages, killing
the majority of these cells over a period
ofdays.
All previous studies which reported
non-covalent binding of chlorambucil to
IgG involved incubation conditions such
that at least some high molecular weight
chlorambucil aggregate would be formed,
and separation techniques which were not
capable of separating this aggregate from
the IgG. We therefore suggest that the
presence of the aggregate has led to gross
over-estimation of the amount of active
chlorambucil which can be non-covalently
bound to IgG. Davies, Buckham and
Manstone (1974) recently concluded, on
the basis of the cytotoxicity experiments,
that selective cytotoxic effects brought
about by combinations of chlorambucil
and tumour specific antibody are due to
the synergistic interaction ofthe drug and
protein rather than to actual physical
conjugates. Our findings support this
view.
We wish to thank Dr Alex Sehon for
his suggestions regarding the chemical
nature of the chlorambucil aggregate.
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